作为抗体-药物结合物的单域抗体:从承诺到实践-系统性审查
Víctor Manuel Medina Pérez1, Marta Baselga1, Alberto J Schuhmacher1,2
1Molecular Oncology Group, Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.
Cancers
|August 10, 2024
概括
单域抗体 (VHHs) 显示出下一代抗体-药物联合体 (ADCs) 的前景. 它们的小尺寸和稳定性提高了瘤的透率,降低了毒性,可能提高了癌症治疗的疗效和安全性.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
背景情况:
- 抗体-药物合物 (ADC) 是强大的向癌症疗法,但面临的挑战是耐药性和副作用.
- 在ADC组件的进步对于提高有效性和安全性至关重要.
研究的目的:
- 评估单域抗体 (VHHs) 作为ADC中常规抗体的替代品.
- 审查VHHs在ADC开发中的现状和潜力,重点关注它们的独特特征.
主要方法:
- 从2014年到2024年,按照PRISMA指南进行系统的文献审查.
- 在主要数据库 (PubMed,Cochrane,ScienceDirect,LILACS) 中搜索ADC和VHH.
- 严格评估和综合对基于VHH的ADC的同行评审文章.
主要成果:
- 与用于药物结合的常规抗体相比,VHHs具有优越的组织透性,稳定性和可制造性.
- 它们的小尺寸允许进入新型表位,一些VHH可以穿过血脑屏障,帮助向脑瘤.
- 虽然VHH-药物合物是临床前的,但正在探索各种合方法和链接器.
结论:
- 通过尽量减少长时间暴露,VHHs的快速分布,瘤透和清除可能会减少ADC的毒性.
- 单域抗体是下一代ADC的强有力的候选者,有可能提高治疗疗效和患者安全.
- 需要进一步了解ADC机制和毒性,以优化治疗策略.
关键词:
这是一个ADCADC ADC.这就是HCAbb.这就是VHH VHH.抗体药物合物 抗体药物合物纳米体是一个纳米体.sdAb sdAb 在线阅读一个单链变量片段的变量片段.单域抗体对合物 单域抗体对合物小格式抗体药物联合体更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.7K
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.4K
相关概念视频
Structure-Activity Relationships and Drug Design
687
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
687
Phase II Conjugation Reactions: Overview
178
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
178
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
